Virgin olive oil administration improves the effect of aspirin on retinal vascular pattern in experimental diabetes mellitus

British Journal of Nutrition

Volumn 104, Issue 4, 2010, Pages 560-565

  De La Cruz, Jose Pedro ^a   Del Río, Sergio ^b   López Villodres, Juan Antonio ^a   Villalobos, Maria Auxiliadora ^c   Jebrouni, Nuria ^a   González Correa, Jose Antonio ^a  

^a UNIVERSIDAD DE MÁLAGA   (Spain)

^b HOSPITAL COSTA DEL SOL   (Spain)

^c UNIVERSITY OF MÁLAGA   (Spain)

Author keywords

Acetylsalicylic acid; Diabetic retinopathy; Nitric oxide; Prostanoids; Virgin olive oil

Indexed keywords

ACETYLSALICYLIC ACID; NITRIC OXIDE; OLIVE OIL; PROSTANOID; THROMBOXANE B2; ANTITHROMBOCYTIC AGENT; HORSERADISH PEROXIDASE; VEGETABLE OIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD CELL COUNT; BODY WEIGHT; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG POTENTIATION; EXPERIMENTAL DIABETES MELLITUS; GENOTYPE; GLUCOSE BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NONHUMAN; PHARMACODYNAMICS; PHENOTYPE; RAT; RETINA BLOOD VESSEL; THROMBOCYTE AGGREGATION; ANIMAL; AORTA; BLOOD; CHEMISTRY; DRUG COMBINATION; DRUG EFFECT; OLIVE TREE; PERMEABILITY; WISTAR RAT;

ARMORACIA RUSTICANA; RATTUS; RATTUS NORVEGICUS;

ANIMALS; AORTA; ASPIRIN; DIABETES MELLITUS, EXPERIMENTAL; DRUG THERAPY, COMBINATION; HORSERADISH PEROXIDASE; MALE; NITRIC OXIDE; OLEA; PERMEABILITY; PLANT OILS; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; RATS; RATS, WISTAR; RETINAL VESSELS; THROMBOXANE B2;

EID: 77956194300     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114510000929     Document Type: Article

References (31)

1. Carr ME (2001) Diabetes mellitus: A hypercoagulable state. J Diabetes Complications 15, 44-54.
2. Colwell JA & Nesto RW (2003) The platelet in diabetes: Focus on prevention of ischemic events. Diabetes Care 26, 2181-2188.
3. De la Cruz JP, Moreno A, Muñoz M, et al. (1997) Effect of aspirin plus dipyridamole on the retinal vascular pattern in experimental diabetes mellitus. J Pharmacol Exp Ther 280, 454-459.
4. Reiss AB & Edelman SD (2006) Recent insights into the role of prostanoids in atherosclerotic vascular disease. Curr Vasc Pharmacol 4, 395-408.
5. De La Cruz JP, Moreno A, Guerrero A, et al. (2002) Nitric oxide-cGMP and prostacyclin-cAMP pathways in patients with type II diabetes and different types of retinopathy. Pathophysiol Haemost Thromb 32, 25-32.
6. De La Cruz JP, Moreno A, Guerrero A, et al. (2001) Antiplatelet effects of prostacyclin and nitric oxide in patients with type I diabetes and ischemic or edematous retinopathy. Platelets 12, 210-217.
7. Schalkwijk CG & Stehouwer CD (2005) Vascular complications in diabetes mellitus: The role of endothelial dysfunction. Clin Sci (Lond) 109, 143-159.
8. De La Cruz JP, Moreno A, Sanchez de la Cuesta F, et al. (1990) Effect of antiplatelet drug therapy on the retinal vascular pattern in experimental diabetes mellitus. Can J Ophthalmol 25, 329-332.
9. De La Cruz JP, Guerrero A, Paniego MJ, et al. (2002) Effect of aspirin on prostanoids and nitric oxide production in streptozotocin-diabetic rats with ischemic retinopathy. Naunyn Schmiedebergs Arch Pharmacol 365, 96-101.
10. De La Cruz JP, Moreno A, Mérida F, et al. (1996) The pyrimido-pyrimidine derivatives, dipyridamole, mopidamol and RA-642, prevent from retinal vascular defects in experimental diabetes mellitus. Thromb Res 81, 327-337.
11. Moreno A, De La Cruz JP, Mérida F, et al. (1995) Effects of ditazol on the vascular retinal pattern in experimental diabetes in rats. Haemostasis 25, 166-171.
12. De La Cruz JP, Moreno A, Ruiz-Ruiz MI, et al. (1998) Effect of camonagrel, a selective thromboxane synthase inhibitor, on retinal vascularization in experimental diabetes. Eur J Pharmacol 350, 81-85.
13. De La Cruz JP, Moreno A, Ruiz-Ruiz MI, et al. (2000) Effect of DT-TX 30, a combined thromboxane synthase inhibitor and thromboxane receptor antagonist, on retinal vascularity in experimental diabetes mellitus. Thromb Res 97, 125-131.
14. De La Cruz JP, Arrebola M, González-Correa JA, et al. (2003) Effects of clopidogrel and ticlopidine on experimental diabetic ischemic retinopathy in rats. Naunyn Schmiedebergs Arch Pharmacol 367, 204-210.
15. Pérez-Jiménez F, Ruano J, Pérez-Martínez P, et al. (2007) The influence of olive oil on human health: Not a question of fat alone. Mol Nutr Food Res 51, 1199-1208.
16. Covas MI (2007) Olive oil and the cardiovascular system. Pharmacol Res 55, 175-186.
17. González-Correa JA, Mũoz-Marín J, Arrebola MM, et al. (2007) Dietary virgin olive oil reduces oxidative stress and cellular damage in rat brain slices subjected to hypoxia- reoxygenation. Lipids 42, 921-929.
18. Glassman AB (1993) Platelet abnormalities in diabetes mellitus. Ann Clin Lab Sci 23, 47-50.
19. Schror K (1997) Blood vessel wall interactions in diabetes. Diabetes 46, Suppl. 2, 115-118.
20. Giugliano D, Ceriello A & Paolisso G (1996) Oxidative stress and diabetic vascular complications. Diabetes Care 19, 257-267.
21. Tesfamariam B & Cohen RA (1992) Role of superoxide anion and endothelium in vasoconstrictor action of prostaglandin endoperoxide. Am J Physiol 262, H1915-H1919.
22. Chakrabarti S, Cukiernik M, Hileeto D, et al. (2000) Role of vasoactive factors in the pathogenesis of early changes in diabetic retinopathy. Diabetes Metab Res Rev 16, 393-407.
23. De Vriese AS, Verbeuren TJ, Van de Voorde J, et al. (2000) Endothelial dysfunction in diabetes. Br J Pharmacol 130, 963-974.
24. De la Cruz JP, Moreno A, Mũoz M, et al. (1997) Effect of aspirin plus dipyridamole on the retinal vascular pattern in experimental diabetes mellitus. J Pharmacol Exp Ther 280, 454-459.
25. González-Correa JA, Arrebola MM, Guerrero A, et al. (2006) Antioxidant and antiplatelet effects of the alphatocopherol- aspirin combination in type 1-like diabetic rats. Life Sci 79, 1405-1412.
26. Vane JR (1971) Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol 231, 232-235.
27. López-Farré A, Caramelo C, Esteban A, et al. (1995) Effect of aspirin on platelet-neutrophil interaction. Role of nitric oxide and endothelin-1. Circulation 91, 2080-2088.
28. De La Cruz JP, Blanco E & Sánchez de la Cuesta F (2000) Effect of dipyridamole and aspirin on the platelet-neutrophil interaction via the nitric oxide pathway. Eur J Pharmacol 397, 35-41.
29. Madajka M, Korda M, White J, et al. (2003) Effect of aspirin on constitutive nitric oxide synthase and the bioavailability of NO. Thromb Res 110, 317-321.
30. Visioli F, Caruso D, Grande S, et al. (2005) Virgin Olive Oil Study (VOLOS): Vasoprotective potential of extra virgin olive oil in mildly dyslipidemic patients. Eur J Nutr 44, 121-127.
31. González-Correa JA, Arrebola MM, Guerrero A, et al. (2006) Antioxidant and antiplatelet effects of the alphatocopherol- aspirin combination in type 1-like diabetic rats. Life Sci 79, 1405-1412.